Strides Pharma Science Limited
Bandhan Mutual Fund increased its stake in Strides Pharma Science from 1.63% to 2.79%, purchasing 10,65,587 shares.
A pharmaceutical manufacturer engaged in developing and producing a diverse range of drug formulations for global distribution. The company operates across multiple therapy segments and maintains manufacturing facilities serving customers in over 100 countries. Strides Pharma has pursued strategic acquisitions and inorganic expansion to strengthen its market presence, diversify business segments, enhance therapy offerings, and build robust production infrastructure.
Formerly IDFC Mutual Fund, rebranded after Bandhan Financial Holdings acquired IDFC's AMC in 2023. Manages over Rs 1.5 lakh crore. Known for strong debt and liquid funds, plus well-regarded equity offerings including the IDFC-lineage Sterling Value Fund and Focused Equity Fund. One of the cleaner transitions in Indian AMC ownership history.